News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

30

2023

-

08

Solidly promote the "Quality Month" activities to help quality work reach a new level | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a Quality Month Knowledge Competition!

Classification:

News


Quality is the core competitiveness related to the survival of an enterprise. Strengthening the construction of a quality enterprise is an effective measure for Keyuan Pharmaceutical (stock code: 301281.SZ) to implement the concept of "lean production and quality first". The company continues to improve the quality system and strengthen training. Learning, creating a quality cultural atmosphere and other means have achieved good results in the construction of a strong quality enterprise. As Keyuan Pharmaceutical's global market strategy continues to advance, the demand for international excellence in quality is growing day by day. During the annual "Quality Month" event, the company launched a series of quality training activities to further enhance the quality awareness of all employees and build on its excellent quality. Quality protects the high-quality development of enterprises and jointly promotes the construction of quality-strong enterprises to a new level.

Keyuan Pharmaceutical held "Quality Month" - Knowledge Contest

11

11

Recently, Keyuan Pharmaceuticals held the "Quality Month" knowledge contest. There are 8 teams from Keyuan Pharmaceutical Factory 1, 2, 3, 4 and 5, warehouse representative team, production office representative team and quality representative team. The team competes. After fierce competition in the mandatory and rush-answer sessions, finally, the No. 5 factory team won the first prize of this knowledge contest.

11

11

11

Keyuan Pharmaceutical has 28 API registration numbers and 41 chemical drug preparation approval numbers. API products mainly include gliclazide, metformin hydrochloride, ropivacaine hydrochloride, isosorbide mononitrate, etc., all of which have passed the national GMP certification, core products have also passed the official pharmaceutical certification of many countries such as EU EDQM certification, US FDA certification, Japanese PMDA certification, Korean KFDA certification, etc., and have strong market competitiveness. Shandong Linuo Pharmaceutical Co., Ltd., a wholly-owned subsidiary, was established in 2002. It is a modern, high-tech new chemical drug manufacturing enterprise integrating the research and development, production and sales of chronic disease drugs. It has 40 drug production approvals and 21 patents. Authorization.

In the future, Keyuan Pharmaceutical will continue to insist on taking quality as the lifeline of enterprise development, thoroughly implement the quality concept of "quality is in my hands, and customers are in my heart", strive for excellence in every product, and strive to build a strong enterprise, a strong province, and a high-quality enterprise. Make greater contributions to the construction of a quality power.

11

Related news

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

The central media theme communication event went to Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical!

2023-08-31

On August 29, the "Central Media High-Quality Development Theme Communication Activity" participated by more than ten media including People's Daily, Xinhua News Agency, Guangming Daily, etc., visited Shandong Keyuan Pharmaceutical Co., Ltd.

Solidly promote the

Solidly promote the "Quality Month" activities to help quality work reach a new level | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a Quality Month Knowledge Competition!

2023-08-30

Quality is the core competitiveness related to the survival of an enterprise. Strengthening the construction of a quality enterprise is an effective measure for Keyuan Pharmaceutical (stock code: 301281.SZ) to implement the concept of "lean production and quality first". The company continues to improve the quality system and strengthen training.

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

Empower quality management and improve quality efficiency | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held a QC group training meeting

2023-08-24

In order to thoroughly implement the theme spirit of "Quality is in my hands and customers are in my heart" for Keyuan Pharmaceutical (stock code: 301281.SZ) Quality Month in 2023, and empower and improve quality management, the Quality Management Center and Human Resources Center held a meeting on August 23 The joint organization carried out a one-day QC group activity training meeting.

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

Start from the heart and embark on a new journey together | Keyuan Pharmaceutical, the parent company of Linuo Pharmaceutical, held an employee theme birthday party and the third cooking competition awards event

2023-08-23

In order to better carry forward the corporate culture spirit of family, one table meal, one heart, one effort, enhance the cohesion and sense of belonging of all employees, enrich the spiritual and cultural life of employees, and let the majority of employees feel that Keyuan Pharmaceutical (stock code: 301281.SZ) The warmth of the big family.